Viral Hepatitis
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 15, 2004; 10(24): 3574-3578
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3574
End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B
Chun-Jen Liu, Wen-Ling Huang, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen
Chun-Jen Liu, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen, Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan, China
Wen-Ling Huang, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen, Graduate Institute of Clinical Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan, China
Jia-Horng Kao, Hepatitis Research Center, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan, China
Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Department of Medical Research, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan, China
Author contributions: All authors contributed equally to the work.
Supported by Grants From the Department of Health, the National Science Council, Executive Yuan, Taiwan; National Taiwan University Hospital (93S022); and Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan
Correspondence to: Professor Jia-Horng Kao, Director, Hepatitis Research Center, National Taiwan University Hospital, 1 Chang-Te St., Taipei 100, Taiwan, China. kjh@ha.mc.ntu.edu.tw
Telephone: +886-2-23123456 Ext. 7307 Fax: +886-2-23317624
Received: February 6, 2004
Revised: March 17, 2004
Accepted: March 24, 2004
Published online: December 15, 2004
Core Tip